SNCA and Parkinson disease: Using state-of-the-art real time quaking induced conversion (Atarashi et al., 2011) of brain homogenates of PD and DLB patients, the authors found that S129 phosphorylation effectively inhibited subsequent fibril formation as well as toxicity associated with α-synuclein.